Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 07, 2022 $20.07 $20.32 $19.08 $19.83 407 300
Apr 06, 2022 $19.82 $20.74 $19.49 $20.29 698 300
Apr 05, 2022 $23.23 $23.23 $19.80 $19.90 1 442 600
Apr 04, 2022 $23.57 $23.71 $22.09 $23.17 785 900
Apr 01, 2022 $23.15 $23.43 $22.39 $22.62 504 448
Mar 31, 2022 $24.28 $24.68 $22.69 $22.73 295 257
Mar 30, 2022 $25.18 $26.17 $23.99 $24.23 306 423
Mar 29, 2022 $23.49 $26.07 $23.49 $25.23 561 900
Mar 28, 2022 $23.53 $24.31 $22.49 $23.22 352 700
Mar 25, 2022 $24.07 $24.10 $22.79 $23.39 408 600
Mar 24, 2022 $22.68 $24.05 $22.24 $24.04 345 200
Mar 23, 2022 $23.06 $24.18 $22.49 $22.52 544 000
Mar 22, 2022 $21.90 $24.26 $21.90 $23.97 791 398
Mar 21, 2022 $24.40 $25.14 $21.72 $21.93 809 274
Mar 18, 2022 $23.08 $25.56 $23.06 $24.98 4 110 831
Mar 17, 2022 $20.69 $23.31 $20.50 $23.17 2 034 500
Mar 16, 2022 $21.40 $22.21 $20.00 $20.92 1 656 100
Mar 15, 2022 $23.00 $24.01 $20.75 $21.00 1 828 400
Mar 14, 2022 $26.13 $27.19 $23.65 $23.78 776 400
Mar 11, 2022 $28.80 $29.90 $26.09 $26.27 425 100
Mar 10, 2022 $28.23 $29.28 $27.17 $27.94 330 600
Mar 09, 2022 $27.68 $29.21 $27.68 $28.88 469 600
Mar 08, 2022 $26.91 $28.60 $25.85 $27.08 605 700
Mar 07, 2022 $27.77 $28.40 $26.38 $26.99 653 700
Mar 04, 2022 $28.29 $29.39 $27.43 $27.65 446 700
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT